Clinical Trial Market Growth 2026 to 2036

Future Market Insights

Clinical Trials Market

Key Insight

The clinical trials market is estimated at USD 131.8 billion in 2026, is projected to reach USD 200.9 billion by 2036 and is forecast to register a 4.3% CAGR between 2026 and 2036. In 2026, phase 3 trials hold ~48% within the trial phase segment.

December 23, 2025

Anurag Sharma

295 Pages

Cite this Report

Clinical Trials Market

https://www.futuremarketinsights.com/reports/clinical-trials-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Charles River Laboratories
ICON plc
IQVIA
Pharmaceutical Product Development (PPD)
Syneos Health

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Clinical Trials Market

Key Players

Similar Industry Reports